retatrutide clinical trial stage 🚨Breaking: Retatrutide's first Phase 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatrutide Results: 28.3% Weight Loss

a Quality of evidence: Studies report their evidence to be of high certainty

Alternativas naturales a los frmacos GLP-1 (para quienes no utilicen semaglutida, tirzepatida, Ozempic, Wegovy o Mounjaro) Si no ests tomando medicamentos recetados con GLP-1 como Ozempic, Wegovy o Mounjaro, an puedes apoyar tu metabolismo, apetito y control de la glucosa a travs de nutrientes especficos

In many cases, it makes physical activity feel more sustainable and less like a prescribed task, he adds

Contact your GP or call 111 if you are concerned about any side effects

The typical progression moves from 2mg during weeks 1 through 4, then 4mg for weeks 5 through 8, and finally 8mg starting at week 9

These studies show that GLP1 patches can work in controlled lab tests on animals, but they do not prove that any GLP1 patch sold to humans today is safe or effective